Trade

with

Alere Inc
(NYSE: ALR)
AdChoices
37.55
-0.31
-0.82%
After Hours :
37.55
0.00
0.00%

Open

38.00

Previous Close

37.86

Volume (Avg)

329.07k (689.25k)

Day's Range

37.07-38.00

52Wk Range

30.96-43.00

Market Cap.

3.12B

Dividend Rate ( Yield )

-

Beta

1.92

Shares Outstanding

83.09M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 3.03B

    • Net Income

    • -71.25M

    • Market Cap.

    • 3.12B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -3.37

    • PEG (Price/Earnings Growth) Ratio

    • 1.57

    • Beta

    • 1.92

    • Forward P/E

    • 14.58

    • Price/Sales

    • 1.04

    • Price/Book Value

    • 2.14

    • Price/Cash flow

    • 11.38

      • EBITDA

      • 574.18M

      • Return on Capital %

      • -1.42

      • Return on Equity %

      • -6.97

      • Return on Assets %

      • -1.42

      • Book Value/Share

      • 17.54

      • Shares Outstanding

      • 83.09M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 36.67

        • Credit Rating

        • B

        • Analysts

        • 4

        • EPS Estimate

        • 1.78

        • Cashflow Estimate

        • 5.30

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -3.40

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -

          • -5.55

          • Net Income

            Q/Q (last year)

          • -

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • 12.63

          • 47.82

          • Net Income

            5-Year Annual Average

          • -

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 48.45

            • 42.70

            • Pre-Tax Margin

            • -4.67

            • 11.63

            • Net Profit Margin

            • -3.37

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 52.00

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -12.60

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • -12.00

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 2.56

              • 0.62

              • Current Ratio

              • 2.25

              • 1.23

              • Quick Ratio

              • 1.40

              • 0.76

              • Interest Coverage

              • 0.38

              • 5.98

              • Leverage Ratio

              • 4.80

              • 2.16

              • Book Value/Share

              • 17.54

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -30.77

                • 33.22

                • P/E Ratio 5-Year High

                • -36.76

                • 325.07

                • P/E Ratio 5-Year Low

                • -14.03

                • 154.73

                • Price/Sales Ratio

                • 1.04

                • 2.34

                • Price/Book Value

                • 2.14

                • 3.04

                • Price/Cash Flow Ratio

                • 11.38

                • 19.08

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -6.97

                    (-12.80)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • -1.42

                    (-4.10)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • 1.00

                    (-2.80)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • -

                  • 17.17k

                  • Inventory Turnover

                  • 4.24

                  • 5.07

                  • Asset Turnover

                  • 0.42

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  134.75M
                  Operating Margin
                  4.45
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  11.38
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  47.36%

                  Mutual Fund Ownership

                  51.45%

                  Float

                  99.42%

                  5% / Insider Ownership

                  1.68%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Standard Life US Small-Cap Equity Fund (Invesco)

                  •  

                    3,499,995

                  • 21.24

                  • 4.21

                  • Edgepoint Global Portfolio

                  •  

                    3,256,291

                  • 0.00

                  • 3.94

                  • Invesco Small Cap Value

                  •  

                    2,886,823

                  • 10.30

                  • 3.49

                  • St James's Pl Global Equity

                  •  

                    2,012,035

                  • 0.00

                  • 2.43

                  • Invesco Select Companies Fund

                  •  

                    1,978,539

                  • -10.16

                  • 2.39

                  • Vanguard Small Cap Index

                  •  

                    1,371,084

                  • 0.25

                  • 1.65

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,279,544

                  • 0.60

                  • 1.54

                  • Edgepoint Global Growth & Income Port

                  •  

                    1,107,612

                  • 0.00

                  • 1.34

                  • Fidelity Advisor® Capital Development

                  •  

                    971,150

                  • 1.36

                  • 1.17

                  • Fidelity® Large Cap Stock Fund

                  •  

                    923,205

                  • 2.16

                  • 1.11

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • EdgePoint Investment Group, Inc.

                  •  

                    8,041,087

                  • +2.88%

                  • 9.68

                  • EdgePoint Investment Management Inc.

                  •  

                    5,166,231

                  • 0.00%

                  • 6.25

                  • Vanguard Group, Inc.

                  •  

                    4,421,211

                  • +2.01%

                  • 5.34

                  • Invesco Advisers, Inc

                  •  

                    3,780,233

                  • +39.23%

                  • 4.57

                  • Scopia Management Inc.

                  •  

                    3,608,080

                  • -3.03%

                  • 4.36

                  • Manning & Napier Advisors, LLC

                  •  

                    3,300,883

                  • -25.51%

                  • 3.97

                  • Dimensional Fund Advisors, Inc.

                  •  

                    3,076,105

                  • +1.84%

                  • 3.72

                  • Orbis Investment Management Limited

                  •  

                    2,719,474

                  • -0.80%

                  • 3.29

                  • Fidelity Management and Research Company

                  •  

                    2,573,623

                  • -18.16%

                  • 3.11

                  • Steinberg Asset Management, LLC

                  •  

                    2,543,239

                  • -5.78%

                  • 3.07

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Speculative Growth

                  Style

                  Small Core

                  Alere Inc formerly known as Inverness Medical Innovations, Inc. is a Delaware corporation incorporated on August 25,1992, which was formed to acquire the women's health, nutritional supplements and professional diagnostics businesses...more of its predecessor, Inverness Medical Technology, Inc., through a split-off and merger transaction, which occurred in November 2001. The Company enables individuals to take control of their health at home, under the supervision of their healthcare providers, by connecting innovative diagnostics in the hands of patients to their healthcare providers. The Company is a provider of point-of-care diagnostics and services; and has developed a strong commercial presence in infectious disease, toxicology, cardiology and diabetes. Its products and services help healthcare practi...moretioners make earlier, more effective treatment decisions and improve outcomes for individuals living with chronic disease. Its portfolio also includes a broad array of health information solutions that increase access to critical health data, provide clinical decision support and facilitate more comprehensive performance reporting and analysis. The Company’s operating segments are professional diagnostics, health information solutions and consumer diagnostics. Professional Diagnostics solutions allow patients and their healthcare providers to work together to better manage patients’ chronic conditions over the continuum of care, from the hospital to home. It is generally designed to assist medical professionals in both preventative and interventional medicine, and include testing and monitoring performed in hospitals, laboratories and doctors’ offices and, increasingly, patient self-testing, which defined as testing or monitoring performed at home under the supervision of a medical professional. Its products provide for qualitative or quantitative analysis of patient samples for evidence of a specific medical condition, disease state or toxicological state or to measure response to therapy. In professional diagnostics, Company focus on point-of-care, rapid diagnostic testing and the developing patient self-testing and patient self-management markets where it can directly and immediately improve patient health outcomes. Its products include point-of-care and laboratory tests within the following areas; Infectious Disease, Toxicology, Cardiology, Diabetes, Oncology, Women’s Health and Connected Device Technologies. Its health information solutions are designed to provide physicians with actionable data that allows them to make more effective decisions in real time, deliver quality care, and put the individuals they treat on a pathway to better health. It offers a variety of software-based analytics, clinical decision-support tools, and accountable care programs that enable healthcare providers to initiate earlier interventions, personalize treatment plans, lower costs by reducing hospital readmissions, and measure improvements in outcomes at both a patient and population level. It is focused on health improvement and accountable care include; Patient Self-testing, Condition and Case Management, Women’s & Children’s Health, and Wellness. Its Consumer Diagnostics segment is a 50/50 joint venture with its affiliates of The Procter & Gamble Company, or P&G, for the development, manufacturing, marketing and sale of existing and to-be-developed consumer diagnostic products, outside the cardiology, diabetes and oral care fields. Its competitors in the United States and abroad are numerous and include, among others, diagnostic testing and medical products companies, universities and other research institutions, health management service providers, healthcare providers and health insurers. The main competitors for its professional rapid diagnostic products are Becton Dickinson, Quidel and Meridian Bioscience. The Company’s businesses are subject to extensive and frequently changing federal, state, local and foreign laws and regulations.lessless

                  Key People

                  Mr. Namal Nawana

                  COO/President/CEO

                  Mr. Gregg Powers

                  Director/Chairman of the Board

                  David Teitel

                  CFO/Chief Accounting Officer/Treasurer/Vice President

                  Mr. John O'Rourke

                  Chief Information Officer

                  Ellen Chiniara

                  General Counsel/Other Executive Officer/Secretary/Vice President

                  • Alere Inc

                  • 51 Sawyer Road

                  • Waltham, MA 02453

                  • USA.Map

                  • Phone: +1 781 647-3900

                  • Fax: +1 781 647-3939

                  • alere.com

                  Incorporated

                  1992

                  Employees

                  17,600

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: